Searchable abstracts of presentations at key conferences in endocrinology

ea0007p289 | Clinical case reports | BES2004

A case of non-classical 11-beta hydroxylase deficiency

Freel E , Wallace M , Fraser R , Davies E , Connell J

A 33 year old male was referred with poorly controlled hypertension. He gave no other past medical or family history. Despite therapy with multiple agents blood pressure was poorly controlled at 200/130 mm/Hg. Initial investigations which included renal ultrasound, magnetic resonance angiography and urine catecholamine excretion were all negative. Plasma renin concentration was suppressed (1 mu/ml/L, normal range 5 to 50) and plasma aldosterone was raised at 650 pmol/L (normal...

ea0005p5 | Bone | BES2003

Determination of a correlation between release of beta c-terminal telopeptides and area of resorption by recombinant rankl-generated human osteoclasts

Chan B , Buckley K , Dutton J , Gallagher J , Fraser W

The discovery of the fundamental involvement of receptor activator for nuclear factor-KB ligand (RANKL) in osteoclast (OC) formation, has enabled the routine generation of human OCs in vitro from human peripheral blood mononuclear cells (PBMCs). Beta C-terminal telopeptide (beta-CTx) is a specific resorption marker for degradation of bone type I collagen by OCs. We have evaluated the correlation between beta-CTx released from dentine wafers on which OC were c...

ea0005p222 | Steroids | BES2003

In vitro expression of human aldosterone synthase and 11-beta hydroxylase

Inglis G , Davies E , Fraser R , Connell J

The key enzymes in the terminal stages of human adrenal gland corticosteroid biosynthesis are aldosterone synthase (AS) and 11-beta hydroxylase (11beta-OHase). Their amino acid sequences differ by only 7% but they exhibit markedly different enzymatic activities. AS is expressed solely in the zona glomerulosa and converts 11-deoxycorticosterone (DOC) to aldosterone whereas 11beta-OHase is expressed mainly in the zona fasciculata and produces cortisol from 11-deoxycortisol. The ...

ea0003p258 | Steroids | BES2002

In vitro expression of catalytically active human aldosterone synthase

Inglis G , Davies E , Stewart P , Fraser R , Connell J

The key enzymes in the terminal stages of human adrenal gland corticosteroid biosynthesis are aldosterone synthase (AS) and 11beta-hydroxylase (11beta-OHase). Their amino acid sequences differ by only 7% but they exhibit markedly different enzymatic activities. AS is expressed solely in the zona glomerulosa and converts 11-deoxycorticosterone (DOC) to aldosterone whereas 11beta-OHase is expressed mainly in the zona fasciculata and produces cortisol from 11-deoxycortisol. The 3...

ea0077oc5.3 | Bone and Calcium | SFEBES2021

Role of Intact and C-Terminal FGF-23 Assays in the Investigation of Metabolic Bone Disease.

Jethwa Kishan , Bhatti Sumbal , Chipchase Allison , Piec Isabelle , Fraser William , Turner Jeremy

Fibroblast growth factor 23 (FGF-23) is a phosphatonin produced by osteocytes in response to serum phosphate concentration. Immunoassays are widely employed to detect C-terminal fragments of FGF-23 (cFGF-23). Quantitative assays for intact FGF-23 (iFGF-23) measurement are also available. Causes of increased FGF-23 include Tumour Induced Osteomalacia (TIO), X-linked hypophosphataemic rickets (XLH) and end stage renal disease (ESRD). We observed that some individuals, with no id...

ea0077op5.2 | Bone and Calcium | SFEBES2021

Society for Endocrinology / Parathyroid UK National Hypoparathyroidism Management Audit

Shen Kiam Jian , Sharma Vivek , Glenister Liz , Fraser William , Turner Jeremy

Individuals with chronic hypoparathyroidism sometimes receive suboptimal care with high frequency of unplanned hospitalisation and iatrogenic harm. In 2015 the European Society for Endocrinology published evidence base consensus guidelines on the management of chronic hypoparathyroidism. Using these consensus recommendations as audit standards we worked with the Society for Endocrinology and Parathyroid UK to conduct a national audit of management of chronic hypoparathyroidism...

ea0081rc13.6 | Rapid Communications 13: Adrenal and Cardiovascular Endocrinology 2 | ECE2022

Mild autonomous cortisol secretion in patients with adrenal incidentalomas and raised cardiovascular risk

Sagar Rebecca , Fraser Sheila , Collins Emma , Frood Russell , Scarsbrook Andrew , M Stewart Paul , Abbas Afroze

Background: Adrenal incidentalomas are common and require investigation to exclude malignancy and evidence of hormone overproduction. Clinical guidelines recommend overnight dexamethasone suppression tests (ONDST) to assess for cortisol hypersecretion with cortisol levels of 50-138 nmol/l termed “mild autonomous cortisol secretion” (MACS). MACS may be associated with both cardiovascular and metabolic morbidity. We assessed cardiovascular risk in patients with MACS us...

ea0081p269 | Adrenal and Cardiovascular Endocrinology | ECE2022

Evaluation of a tertiary centre specialist adrenal MDT: The first 900 patients

Child Louisa , Sagar Rebecca , Fraser Sheila , Collins Emma , Frood Russell , Scarsbrook Andrew , Abbas Afroze

Background: Adrenal incidentalomas are common amongst the general population, incidence increases with age. Radiological and biochemical assessment of all lesions >1 cm is standard practice to determine appropriate future management, as per current European guidelines. We report the experiences of a recently formalised adrenal multi-disciplinary pathway in a large UK teaching hospital, where all adrenal incidentalomas are referred and systematically assessed.<p cl...

ea0050p277 | Neuroendocrinology and Pituitary | SFEBES2017

Copeptin during hypertonic saline infusion in a polyuria/polydipsia syndrome case series

Boot Christopher , James R Andrew , Tsatlidis Vasileios , Gibb Fraser , Green Fiona , Neely R Dermot G

Introduction: Copeptin is the C-terminal fragment of proAVP and provides an alternative measure of AVP secretion. While direct measurement of AVP during hypertonic saline infusion has been recommended as a diagnostic test for diabetes insipidus (DI), the number of reports examining the utility of copeptin in this context is limited. Here we describe a series of cases where measurement of copeptin during saline infusion has contributed to ...

ea0050p277 | Neuroendocrinology and Pituitary | SFEBES2017

Copeptin during hypertonic saline infusion in a polyuria/polydipsia syndrome case series

Boot Christopher , James R Andrew , Tsatlidis Vasileios , Gibb Fraser , Green Fiona , Neely R Dermot G

Introduction: Copeptin is the C-terminal fragment of proAVP and provides an alternative measure of AVP secretion. While direct measurement of AVP during hypertonic saline infusion has been recommended as a diagnostic test for diabetes insipidus (DI), the number of reports examining the utility of copeptin in this context is limited. Here we describe a series of cases where measurement of copeptin during saline infusion has contributed to ...